SEI Trust Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SEI Trust Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$537K	Buy	+10,320	New	+$526K	0.01%	1076

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

SEI Trust Company's XBI Position: Q3 2014 in Review

SEI Trust Company opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2014: 10,320 shares worth $537K. The stake represents 0.01% of the portfolio and ranks #1076 among its holdings.

129 funds tracked by Wall St. Rank hold XBI as of Q3 2014.

SEI Trust Company held 10,320 shares of State Street SPDR S&P Biotech ETF worth $537K as of Q3 2014.
State Street SPDR S&P Biotech ETF was a new SEI Trust Company position in Q3 2014.
State Street SPDR S&P Biotech ETF made up 0.01% of SEI Trust Company's portfolio in Q3 2014, its #1076 holding.
129 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.